| # | Drug | Count |
|---|---|---|
| 0 | RIVAROXABAN | 29 |
| 1 | CISPLATIN | 28 |
| 2 | CLOPIDOGREL | 28 |
| 3 | CLOPIDOGREL BISULFATE | 28 |
| 4 | OMEPRAZOLE MAGNESIUM | 26 |
| 5 | GABAPENTIN | 23 |
| 6 | OMEPRAZOLE | 23 |
| 7 | ACETAMINOPHEN | 22 |
| 8 | PREDNISONE | 20 |
| 9 | BISOPROLOL FUMARATE | 19 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DEXTRAN 40 | 2 | 0.0278 |
| 1 | PIVMECILLINAM | 2 | 0.0106 |
| 2 | BEVACIZUMAB-MALY | 1 | 0.0050 |
| 3 | TOREMIFENE CITRATE | 2 | 0.0046 |
| 4 | ALCLOMETASONE DIPROPIONATE | 1 | 0.0032 |
| 5 | CARBIDOPA TABLETS | 7 | 0.0023 |
| 6 | ORPHENADRINE CITRATE | 1 | 0.0016 |
| 7 | ARGATROBAN | 2 | 0.0013 |
| 8 | NEVIRAPINE | 11 | 0.0012 |
| 9 | ABACAVIR SULFATE | 11 | 0.0011 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 54 |
| 1 | Factor Xa Inhibitor [EPC] | 43 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 42 |
| 3 | Platinum-based Drug [EPC] | 38 |
| 4 | Proton Pump Inhibitor [EPC] | 35 |
| 5 | Kinase Inhibitor [EPC] | 32 |
| 6 | P2Y12 Platelet Inhibitor [EPC] | 28 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 20 |
| 8 | Nucleoside Metabolic Inhibitor [EPC] | 18 |
| 9 | Dihydropyridine Calcium Channel Blocker [EPC] | 17 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anti-coagulant [EPC] | 3 | 0.0008 |
| 1 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 6 | 0.0007 |
| 2 | Claudin 18.2-directed Cytolytic Antibody [EPC] | 1 | 0.0007 |
| 3 | Plasma Volume Expander [EPC] | 2 | 0.0006 |
| 4 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 5 | Human Immunoglobulin G [EPC] | 10 | 0.0005 |
| 6 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 11 | 0.0005 |
| 7 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 8 | Phosphate Binder [EPC] | 1 | 0.0003 |
| 9 | Epidermal Growth Factor Receptor Antagonist [EPC] | 13 | 0.0003 |